These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10332056)

  • 21. Influence of degree of substitution of HES-HEMA on the release of incorporated drug models from corresponding hydrogels.
    Schwoerer AD; Harling S; Scheibe K; Menzel H; Daniels R
    Eur J Pharm Biopharm; 2009 Nov; 73(3):351-6. PubMed ID: 19683570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparing polymer-based sustained-release systems without exposing proteins to water-oil or water-air interfaces and cross-linking reagents.
    Jin T; Zhu J; Wu F; Yuan W; Geng LL; Zhu H
    J Control Release; 2008 May; 128(1):50-9. PubMed ID: 18417240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mobility of model proteins in hydrogels composed of oppositely charged dextran microspheres studied by protein release and fluorescence recovery after photobleaching.
    Van Tomme SR; De Geest BG; Braeckmans K; De Smedt SC; Siepmann F; Siepmann J; van Nostrum CF; Hennink WE
    J Control Release; 2005 Dec; 110(1):67-78. PubMed ID: 16253375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biphasic release of protein from polyethylene glycol and polyethylene glycol/modified dextran microspheres.
    Nguyen HX; O'Rear EA
    J Biomed Mater Res A; 2013 Sep; 101(9):2699-705. PubMed ID: 23427111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of aqueous PEG/dextran phase separation for the preparation of dextran microspheres.
    Stenekes RJ; Franssen O; van Bommel EM; Crommelin DJ; Hennink WE
    Int J Pharm; 1999 Jun; 183(1):29-32. PubMed ID: 10361149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Degradable dextran microspheres for the controlled release of liposomes.
    Stenekes RJ; Loebis AE; Fernandes CM; Crommelin DJ; Hennink WE
    Int J Pharm; 2001 Feb; 214(1-2):17-20. PubMed ID: 11282230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physically crosslinked dextran hydrogels by stereocomplex formation of lactic acid oligomers: degradation and protein release behavior.
    de Jong SJ; van Eerdenbrugh B; van Nostrum CF; Kettenes-van den Bosch JJ; Hennink WE
    J Control Release; 2001 Apr; 71(3):261-75. PubMed ID: 11295219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of polymerization conditions on the network properties of dex-HEMA microspheres and macro-hydrogels.
    Chung JT; Vlugt-Wensink KD; Hennink WE; Zhang Z
    Int J Pharm; 2005 Jan; 288(1):51-61. PubMed ID: 15607257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Self-assembled hydrogel nanoparticles composed of dextran and poly(ethylene glycol) macromer.
    Kim IS; Jeong YI; Kim SH
    Int J Pharm; 2000 Sep; 205(1-2):109-16. PubMed ID: 11000547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New biodegradable dextran-based hydrogels for protein delivery: Synthesis and characterization.
    Pacelli S; Paolicelli P; Casadei MA
    Carbohydr Polym; 2015 Aug; 126():208-14. PubMed ID: 25933541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Photocrosslinking of dextran and polyaspartamide derivatives: a combination suitable for colon-specific drug delivery.
    Pitarresi G; Casadei MA; Mandracchia D; Paolicelli P; Palumbo FS; Giammona G
    J Control Release; 2007 Jun; 119(3):328-38. PubMed ID: 17475357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity of meningococcal PorA formulations encapsulated in biodegradable microspheres.
    Arigita C; van den Berg J; Wensink K; van Steenbergen M; Hennink WE; Crommelin DJ; Kersten GF; Jiskoot W
    Eur J Pharm Sci; 2004 Feb; 21(2-3):131-41. PubMed ID: 14757484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crosslinked Dextran Gel Microspheres with Computed Tomography Angiography and Drug Release Function.
    Zhu C; Ma X; Ma D; Zhang T; Gu N
    J Nanosci Nanotechnol; 2018 Apr; 18(4):2931-2937. PubMed ID: 29442976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of particle size and charge on the network properties of microsphere-based hydrogels.
    Van Tomme SR; van Nostrum CF; Dijkstra M; De Smedt SC; Hennink WE
    Eur J Pharm Biopharm; 2008 Oct; 70(2):522-30. PubMed ID: 18582574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anionic and cationic dextran hydrogels for post-loading and release of proteins.
    Schillemans JP; Verheyen E; Barendregt A; Hennink WE; Van Nostrum CF
    J Control Release; 2011 Mar; 150(3):266-71. PubMed ID: 21130815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Periodontal regeneration using novel glycidyl methacrylated dextran (Dex-GMA)/gelatin scaffolds containing microspheres loaded with bone morphogenetic proteins.
    Chen FM; Zhao YM; Zhang R; Jin T; Sun HH; Wu ZF; Jin Y
    J Control Release; 2007 Aug; 121(1-2):81-90. PubMed ID: 17617489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biodegradable recombinant human erythropoietin loaded microspheres prepared from linear and star-branched block copolymers: influence of encapsulation technique and polymer composition on particle characteristics.
    Pistel KF; Bittner B; Koll H; Winter G; Kissel T
    J Control Release; 1999 Jun; 59(3):309-25. PubMed ID: 10332063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stabilization and controlled release of bovine serum albumin encapsulated in poly(D, L-lactide) and poly(ethylene glycol) microsphere blends.
    Jiang W; Schwendeman SP
    Pharm Res; 2001 Jun; 18(6):878-85. PubMed ID: 11474795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo biocompatibility of dextran-based hydrogels.
    Cadée JA; van Luyn MJ; Brouwer LA; Plantinga JA; van Wachem PB; de Groot CJ; den Otter W; Hennink WE
    J Biomed Mater Res; 2000 Jun; 50(3):397-404. PubMed ID: 10737882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of network charge on the immobilization and release of proteins from chemically crosslinked dextran hydrogels.
    Schillemans JP; Hennink WE; van Nostrum CF
    Eur J Pharm Biopharm; 2010 Nov; 76(3):329-35. PubMed ID: 20708077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.